This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 115/16/2178    most recent CIRCULATIONAHA.106.664250v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lewis, P. Articles by de Haan, J. B. Search for Related Content PubMed PubMed Citation Articles by Lewis, P. Articles by de Haan, J. B. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB L-TYROSINE STREPTOZOTOCIN Related Collections Animal models of human disease Gene expression Genetically altered mice Type 1 diabetes Mechanism of atherosclerosis/growth factors

(Circulation. 2007;115:2178-2187.)
© 2007 American Heart Association, Inc.

Molecular Cardiology

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

Paul Lewis, BSc, LLB (Hons); Nada Stefanovic, BSc; Josefa Pete, BSc (Hons); Anna C. Calkin, PhD; Sara Giunti, MD, PhD; Vicki Thallas-Bonke, BAppSci; Karin A. Jandeleit-Dahm, MD, PhD; Terri J. Allen, PhD; Ismail Kola, PhD; Mark E. Cooper, MBBS, FRACP, PhD; Judy B. de Haan, MSc, PhD

From Oxidative Stress Group (P.L., N.S., J.B.d.H.) and Diabetic Complications Group (J.P., A.C.C., S.G., V.T.-B., K.A.J.-D., T.J.A., M.E.C.), JDRF Diabetes and Metabolism Division, Baker Heart Research Institute, Melbourne, Australia; and Merck Research Laboratories (I.K.), Merck & Co, Inc, Rahway, NJ. Dr Kola is now Senior Vice President, Discovery Research, at Schering-Plough Research Institute (SPRI), Schering-Plough Corporation, Kenilworth, NJ. He is also Chief Scientific Officer for Schering-Plough Corporation.

Correspondence to Judy B. de Haan, Head: Oxidative Stress Group, JDRF Diabetes and Metabolism Division, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, VIC 8008, Australia. E-mail judy.dehaan{at}baker.edu.au

Received September 11, 2006; accepted February 21, 2007.

Background— Recent clinical studies have suggested a major protective role for the antioxidant enzyme glutathione peroxidase-1 (GPx1) in diabetes-associated atherosclerosis. We induced diabetes in mice deficient for both GPx1 and apolipoprotein E (ApoE) to determine whether this is merely an association or whether GPx1 has a direct effect on diabetes-associated atherosclerosis.

Methods and Results— ApoE-deficient (ApoE^–/–) and ApoE/GPx1 double-knockout (ApoE^–/–GPx1^–/–) mice were made diabetic with streptozotocin and aortic lesion formation, and atherogenic pathways were assessed after 10 and 20 weeks of diabetes. Aortic proinflammatory and profibrotic markers were determined by both quantitative reverse-transcription polymerase chain reaction analysis after 10 weeks of diabetes and immunohistochemical analysis after 10 and 20 weeks of diabetes. Sham-injected nondiabetic counterparts served as controls. Atherosclerotic lesions within the aortic sinus region, as well as arch, thoracic, and abdominal lesions, were significantly increased in diabetic ApoE^–/–GPx1^–/– aortas compared with diabetic ApoE^–/– aortas. This increase was accompanied by increased macrophages, -smooth muscle actin, receptors for advanced glycation end products, and various proinflammatory (vascular cell adhesion molecule-1) and profibrotic (vascular endothelial growth factor and connective tissue growth factor) markers. Quantitative reverse-transcription polymerase chain reaction analysis showed increased expression of receptors for advanced glycation end products (RAGE), vascular cell adhesion molecule-1, vascular endothelial growth factor, and connective tissue growth factor. Nitrotyrosine levels were significantly increased in diabetic ApoE^–/–GPx1^–/– mouse aortas. These findings were observed despite upregulation of other antioxidants.

Conclusions— Lack of functional GPx1 accelerates diabetes-associated atherosclerosis via upregulation of proinflammatory and profibrotic pathways in ApoE^–/– mice. Our study provides evidence of a protective role for GPx1 and establishes GPx1 as an important antiatherogenic therapeutic target in patients with or at risk of diabetic macrovascular disease.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				A. H. Wagner, O. Kautz, K. Fricke, M. Zerr-Fouineau, E. Demicheva, B. Guldenzoph, J. L. Bermejo, T. Korff, and M. Hecker Upregulation of Glutathione Peroxidase Offsets Stretch-Induced Proatherogenic Gene Expression in Human Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1894 - 1901. [Abstract] [Full Text] [PDF]

				P. Chew, D. Y.C. Yuen, P. Koh, N. Stefanovic, M. A. Febbraio, I. Kola, M. E. Cooper, and J. B. de Haan Site-Specific Antiatherogenic Effect of the Antioxidant Ebselen in the Diabetic Apolipoprotein E-Deficient Mouse Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 823 - 830. [Abstract] [Full Text] [PDF]

				A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P. L. Jones, R. G. Roeder, M. E. Cooper, and M. Brownlee Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia J. Exp. Med., September 29, 2008; 205(10): 2409 - 2417. [Abstract] [Full Text] [PDF]

				A. Soro-Paavonen, A. M.D. Watson, J. Li, K. Paavonen, A. Koitka, A. C. Calkin, D. Barit, M. T. Coughlan, B. G. Drew, G. I. Lancaster, et al. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes Diabetes, September 1, 2008; 57(9): 2461 - 2469. [Abstract] [Full Text] [PDF]

				K. G. Maier Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Diabetes: Vascular Implications Vascular and Endovascular Surgery, August 1, 2008; 42(4): 305 - 313. [Abstract] [PDF]

				G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies Cardiovasc Res, May 1, 2008; 78(2): 265 - 273. [Abstract] [Full Text] [PDF]

				H. Zhu, Z. Jia, L. Zhang, M. Yamamoto, H. P. Misra, M. A. Trush, and Y. Li Antioxidants and Phase 2 Enzymes in Macrophages: Regulation by Nrf2 Signaling and Protection Against Oxidative and Electrophilic Stress Experimental Biology and Medicine, April 1, 2008; 233(4): 463 - 474. [Abstract] [Full Text] [PDF]